CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...
Abselion has expanded its Amperia™ platform with a Tagged Protein Quantification Kit | His-tag and a Tagged Protein Sensor | ...
The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a 1.4 million–protein PBMC dataset available in the Nomic Portal Nomic Bio (“Nomic” ...
The Amperia ™ benchtop instrument measures proteins and viral vectors quickly and accurately, even from complicated samples. This benchtop device has no optical or fluidic components, ensuring ...
As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
Despite major advances in LC-MS, achieving consistent protein quantification remains challenging in early drug discovery. Complex matrices and limited sensitivity often hinder reliable biomarker ...
Precise protein quantification is a crucial step in workflows involving protein extraction, isolation, and analysis. Accurate knowledge of the concentration of your protein sample is essential for ...
The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results